Leal, A.S.; Liu, P.; Krieger-Burke, T.; Ruggeri, B.; Liby, K.T.
The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer. Cancers 2021, 13, 96.
https://doi.org/10.3390/cancers13010096
AMA Style
Leal AS, Liu P, Krieger-Burke T, Ruggeri B, Liby KT.
The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer. Cancers. 2021; 13(1):96.
https://doi.org/10.3390/cancers13010096
Chicago/Turabian Style
Leal, Ana S., Phillip Liu, Teresa Krieger-Burke, Bruce Ruggeri, and Karen T. Liby.
2021. "The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer" Cancers 13, no. 1: 96.
https://doi.org/10.3390/cancers13010096
APA Style
Leal, A. S., Liu, P., Krieger-Burke, T., Ruggeri, B., & Liby, K. T.
(2021). The Bromodomain Inhibitor, INCB057643, Targets Both Cancer Cells and the Tumor Microenvironment in Two Preclinical Models of Pancreatic Cancer. Cancers, 13(1), 96.
https://doi.org/10.3390/cancers13010096